2 May 2022 in European Journal of Cardio-Thoracic Surgery
OBJECTIVES: Surgery of the aortic root in acute aortic dissection type A (AADA) remains a topic of vague evidence since the extend of dissection and surgeons’ capability and interpretation of the disease vary remarkably. We aimed to interpret root operation strategies in the German Registry for Acute Aortic Dissection cohort.METHODS: German Registry for Acute Aortic Dissection collected the data of 56 centres between July 2006 and June 2015. A total of 3382 patients undergoing operations for AADA were included and divided into 3 groups according to aortic root procedure types: supracommissural replacement (SCR), conduit replacement (CR) and valve sparing root replacement (VSRR).RESULTS: Patients in SCR (2425, 71.7%) were significantly older than CR (681, 20.1%) and VSRR (276, 8.2%) (63.4 vs 57.5 vs 54.2 years; P < 0.001), more female (38.9% vs 32.0% vs 26.1%; P < 0.001) and presented with less aortic regurgitation (26.3% vs 57.1% vs 56.5%; P < 0.001). VSRR presented with slightly less multiple organ malperfusion (11.6% vs 12.0% vs 10.9%; P = 0.045) and were more often diagnosed for Marfan syndrome (2.4% vs 5.1% vs 9.1%; P < 0.001). Thirty-day mortality was lower for VSRR (11.6%) compared to SCR (16.1%) and CR (19.8%; P = 0.010). Despite longer procedural times, multivariable regression showed no influence of total arch replacement for VSRR on mortality compared to CR (odds ratio 0.264; 95% confidence interval, 0.033–2.117; P = 0.21).CONCLUSIONS: SCR remains the procedure of choice in elderly and compromised patients. Extended root preservation techniques may be applied even in combination with extended aortic arch surgery for selected patients for AADA with promising early outcomes.
1 May 2011 in Tissue Engineering Part A
Objectives: Tissue-engineered arterial vessels (TEAV) offer substantial advantages in small-calibered human-bypass-grafting and vascularized scaffold applications. However, histological composition of TEAV must allow for functional properties, such as vasomotoricity. Aim of this study was to characterize human TEAVs regarding morphology and vasomotoricity. Methods: Three groups containing segments of porcine carotid artery <5 mm in diameter (native [NA, n = 6], decellularized [DA, n = 6], and decellularized/reseeded in a bioreactor [RA, n = 7] with human vascular endothelial [hvECs] and smooth muscle cells [hvSMCs]) were examined. Light and scanning electron microscopy were applied, and hvSMCs- and hvECs-associated Vasomotoricity Test conducted in Krebs-solution was used for characterization of revitalized TEAVs. Results: Morphologic examination showed cell-free extracellular matrix in DAs. Light microscopy demonstrated intact extracellular matrix components in circle-layered formation in cross sections of DAs. RAs showed small cells migrating along the remaining medial fiber structures and flat cell layers at the luminal site, identified as hvECs and hvSMCs with lower CD-31 and α-actin signaling than controls. Scanning electron microscopy showed intact flat cell layers on luminal surfaces of RAs and dense hvSMCs at their media site. DAs showed decreasing strain after stimulation. RAs retrieved vasomotoricity compared to DAs, but showed reduced contraction and incomplete relaxation compared to NAs. Conclusions: This study shows that revitalization of DA with human vascular cells resembles NA-like morphology and can ensure vasomotoricity of TEAVs.
1 April 2020 in The Journal of Heart and Lung Transplantation
23 January 2013 in The Thoracic and Cardiovascular Surgeon
Objectives: Vascular changes associated with the Marfan syndrome are characterised by an abnormally high activity of matrix metalloproteinases (MMPs) in aortic smooth muscle cells leading to destruction of collagen fibres. It has been shown that the transcription factor activating factor-1 (AP-1) plays a pivotal role in the regulation of MMP expression. In the present study we aimed to decrease MMP-2 and MMP-9-expression and subsequent activity in cultured cells by a decoy deoxyoligoribonucleotide (dODN)-mediated neutralization of AP-1. Methods: To analyze dODN function, murine aortal smooth muscle cells (mAoSMC) from fibrillin-1 deficient marfan mice (mgR/mgR), mAoSMC from wildtype (wt) -mice and human umbilical arterial smooth muscle cells (HUASMC) were used. Interleukin-1β (IL-1β)/fMLP- and non-stimulated cells were compared to dODN pretreated stimulated cells. We rated the MMP-2 and MMP-9 expression and subsequent activity by using western blot, gelatine-zymography and immonoprecipitation combined with gelatine-zymography. In addition, we tested the penetration depth of a ATTO-590 fluorescent dODN (fODN) in the aorta of mgR/mgR-and wt-mice. Results: MAoSMC of Marfan mice expressed significantly more MMP-2 and MMP-9 than mAoSMC from wild type mice (p = 0.016). In all cultured cells reduction of basal MMP-2 and MMP-9 expression could be observed after AP-1 dODN application. After stimulation of mAoSMC-wt with IL1β, treatment with dODN resulted in reduction of MMP-9 expression by 87% compared to untreated controls (p = 0.016). Similarly, MMP-2 activity was reduced by 50% (p = 0.025). Comparably in mgR/mgR-mAoSMC the MMP-2 activity was reduced by 70% (p = 0.002).This downregulation of MMPs by dODN was also observed in human cells (HUASMC), resulting in reduction of expression of MMP-9 by 80% (p = 0.025) and reduction of activity of MMP-2 by 190% (p = 0.025). Moreover, fluorescent microscopy identified the fODN in the SMC of the aortic media of mgR/mgR but not in SMC of the aortic media of wt-mice, demonstrating that dODN can overcome the endothelial cell barrier only in mgR/mgR-mice. Conclusion: Neutralization of the AP-1 transcription factor resulted in a significant inhibition of MMP expression and activity. This effect was more pronounced in Marfan mice compared to wt- animals due to elevated MMP-levels. Increased permeability for fODN may be related to an endothelial cell dysfunction in mgR/mgR aortas, offering new potential therapeutic strategies using dODNs.